Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-Lumefantrine Suspension vs. Tablets for Malaria in Children
NCT00529867Phase 4Completed
- Sponsor
- Dafra Pharma
- Start
- May 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether, lumefantrine in Malaria, sponsored by Dafra Pharma. Started May 2007; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00529867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529867.